Acepromazine
Hydrotalcite can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aceprometazine
Hydrotalcite can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alclometasone
The bioavailability of Alclometasone can be decreased when combined with Hydrotalcite.
Advertisement
Aldosterone
The bioavailability of Aldosterone can be decreased when combined with Hydrotalcite.
Alendronate
The serum concentration of Alendronic acid can be decreased when it is combined with Hydrotalcite.
Alendronic acid
The serum concentration of Alendronic acid can be decreased when it is combined with Hydrotalcite.
Advertisement
Allopurinol
Hydrotalcite can cause a decrease in the absorption of Allopurinol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amcinonide
The bioavailability of Amcinonide can be decreased when combined with Hydrotalcite.
Amphetamine
Hydrotalcite may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Advertisement
Androstenedione
The bioavailability of Androstenedione can be decreased when combined with Hydrotalcite.
Atazanavir
Hydrotalcite can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atorvastatin
The serum concentration of Atorvastatin can be decreased when it is combined with Hydrotalcite.
Beclomethasone Dipropionate
The bioavailability of Beclomethasone dipropionate can be decreased when combined with Hydrotalcite.
Benzphetamine
Hydrotalcite may decrease the excretion rate of Benzphetamine which could result in a higher serum level.
Betamethasone
The bioavailability of Betamethasone can be decreased when combined with Hydrotalcite.
Bisacodyl
The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Hydrotalcite.
Bismuth Subcitrate
The therapeutic efficacy of Bismuth Subcitrate can be decreased when used in combination with Hydrotalcite.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Hydrotalcite.
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Hydrotalcite.
Budesonide
The bioavailability of Budesonide can be decreased when combined with Hydrotalcite.
Captopril
Hydrotalcite can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Hydrotalcite.
Cefpodoxime
The serum concentration of Cefpodoxime can be decreased when it is combined with Hydrotalcite.
Cefuroxime
The serum concentration of Cefuroxime can be decreased when it is combined with Hydrotalcite.
Cerivastatin
The serum concentration of Cerivastatin can be decreased when it is combined with Hydrotalcite.
Chloroquine
The serum concentration of Chloroquine can be decreased when it is combined with Hydrotalcite.
Chlorpromazine
Hydrotalcite can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Chlortetracycline
Hydrotalcite can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ciclesonide
The bioavailability of Ciclesonide can be decreased when combined with Hydrotalcite.
Cinoxacin
Hydrotalcite can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Clobetasol
The bioavailability of Clobetasol can be decreased when combined with Hydrotalcite.
Clobetasol Propionate
The bioavailability of Clobetasol propionate can be decreased when combined with Hydrotalcite.
Clobetasone
The bioavailability of Clobetasone can be decreased when combined with Hydrotalcite.
Clocortolone
The bioavailability of Clocortolone can be decreased when combined with Hydrotalcite.
Clodronic Acid
The serum concentration of Clodronic Acid can be decreased when it is combined with Hydrotalcite.
Cortisone Acetate
The bioavailability of Cortisone acetate can be decreased when combined with Hydrotalcite.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Hydrotalcite.
Dabigatran Etexilate
The serum concentration of Dabigatran etexilate can be decreased when it is combined with Hydrotalcite.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Hydrotalcite.
Dasatinib
Hydrotalcite can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dasatinib Anhydrous
Hydrotalcite can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Hydrotalcite.
Deflazacort
The bioavailability of Deflazacort can be decreased when combined with Hydrotalcite.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Hydrotalcite.
Demeclocycline
Hydrotalcite can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Desonide
The bioavailability of Desonide can be decreased when combined with Hydrotalcite.
Desoximetasone
The bioavailability of Desoximetasone can be decreased when combined with Hydrotalcite.
Desoxycorticosterone acetate
The bioavailability of Desoxycorticosterone acetate can be decreased when combined with Hydrotalcite.
Desoxycorticosterone Pivalate
The bioavailability of Desoxycorticosterone Pivalate can be decreased when combined with Hydrotalcite.
Dexamethasone
The bioavailability of Dexamethasone can be decreased when combined with Hydrotalcite.
Dexmethylphenidate
Hydrotalcite can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Hydrotalcite may decrease the excretion rate of Dextroamphetamine which could result in a higher serum level.
Dibasic potassium phosphate
Hydrotalcite can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Diethylpropion
Hydrotalcite may decrease the excretion rate of Diethylpropion which could result in a higher serum level.
Diflorasone
The bioavailability of Diflorasone can be decreased when combined with Hydrotalcite.
Diflucortolone
The bioavailability of Difluocortolone can be decreased when combined with Hydrotalcite.
Difluprednate
The bioavailability of Difluprednate can be decreased when combined with Hydrotalcite.
Dolutegravir
The serum concentration of Dolutegravir can be decreased when it is combined with Hydrotalcite.
Doxycycline
Hydrotalcite can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline Anhydrous
Hydrotalcite can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Elvitegravir
The serum concentration of Elvitegravir can be decreased when it is combined with Hydrotalcite.
Enoxacin
Hydrotalcite can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Hydrotalcite.
Estrone
The bioavailability of Estrone can be decreased when combined with Hydrotalcite.
Etidronate
The serum concentration of Etidronic acid can be decreased when it is combined with Hydrotalcite.
Etidronic Acid
The serum concentration of Etidronic acid can be decreased when it is combined with Hydrotalcite.
Ferric Carboxymaltose
Hydrotalcite can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Hydrotalcite can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fexofenadine
The serum concentration of Fexofenadine can be decreased when it is combined with Hydrotalcite.
Fleroxacin
Hydrotalcite can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fludrocortisone
The bioavailability of Fludrocortisone can be decreased when combined with Hydrotalcite.
Flumequine
Hydrotalcite can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Flumethasone
The bioavailability of Flumethasone can be decreased when combined with Hydrotalcite.
Flunisolide
The bioavailability of Flunisolide can be decreased when combined with Hydrotalcite.
Flunisolide Anhydrous (obsolete)
The bioavailability of Flunisolide can be decreased when combined with Hydrotalcite.
Fluocinolone Acetonide
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Hydrotalcite.
Fluocinonide
The bioavailability of Fluocinonide can be decreased when combined with Hydrotalcite.
Fluocortolone
The bioavailability of Fluocortolone can be decreased when combined with Hydrotalcite.
Fluorometholone
The bioavailability of Fluorometholone can be decreased when combined with Hydrotalcite.
Fluphenazine
Hydrotalcite can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
FLUPREDNIDENE
The bioavailability of Fluprednidene can be decreased when combined with Hydrotalcite.
Fluprednisolone
The bioavailability of Fluprednisolone can be decreased when combined with Hydrotalcite.
Flurandrenolide
The bioavailability of Flurandrenolide can be decreased when combined with Hydrotalcite.
Fluticasone Furoate
The bioavailability of Fluticasone furoate can be decreased when combined with Hydrotalcite.
Fluticasone propionate
The bioavailability of Fluticasone propionate can be decreased when combined with Hydrotalcite.
Fluvastatin
The serum concentration of Fluvastatin can be decreased when it is combined with Hydrotalcite.
Formestane
The bioavailability of Formestane can be decreased when combined with Hydrotalcite.
Fosinopril
Hydrotalcite can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gabapentin
The serum concentration of Gabapentin can be decreased when it is combined with Hydrotalcite.
Gatifloxacin
Hydrotalcite can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gatifloxacin Anhydrous
Hydrotalcite can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Hydrotalcite.
Gemifloxacin
Hydrotalcite can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gemifloxacin Mesylate
Hydrotalcite can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Grepafloxacin
Hydrotalcite can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Halcinonide
The bioavailability of Halcinonide can be decreased when combined with Hydrotalcite.
Halobetasol
The bioavailability of Ulobetasol can be decreased when combined with Hydrotalcite.
Hydrocortisone
The bioavailability of Hydrocortisone can be decreased when combined with Hydrotalcite.
Hyoscyamine
The serum concentration of Hyoscyamine can be decreased when it is combined with Hydrotalcite.
Ibandronate
The serum concentration of Ibandronate can be decreased when it is combined with Hydrotalcite.
Ibandronic Acid
The serum concentration of Ibandronate can be decreased when it is combined with Hydrotalcite.
Iron
Hydrotalcite can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Hydrotalcite can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Hydrotalcite can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Hydrotalcite can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isoniazid
Hydrotalcite can cause a decrease in the absorption of Isoniazid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Hydrotalcite.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Hydrotalcite.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Hydrotalcite.
Levofloxacin
Hydrotalcite can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levofloxacin Anhydrous
Hydrotalcite can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lisdexamfetamine
Hydrotalcite may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.
Lisdexamfetamine Dimesylate
Hydrotalcite may decrease the excretion rate of Lisdexamfetamine which could result in a higher serum level.
Loteprednol
The bioavailability of Loteprednol can be decreased when combined with Hydrotalcite.
Lovastatin
The serum concentration of Lovastatin can be decreased when it is combined with Hydrotalcite.
Mecamylamine
The serum concentration of Mecamylamine can be increased when it is combined with Hydrotalcite.
Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Hydrotalcite.
Medrysone
The bioavailability of Medrysone can be decreased when combined with Hydrotalcite.
Memantine
The serum concentration of Memantine can be increased when it is combined with Hydrotalcite.
Mephentermine
Hydrotalcite may decrease the excretion rate of Mephentermine which could result in a higher serum level.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Hydrotalcite.
Mesoridazine
Hydrotalcite can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methamphetamine
Hydrotalcite may decrease the excretion rate of Methamphetamine which could result in a higher serum level.
Methenamine
The therapeutic efficacy of Methenamine can be decreased when used in combination with Hydrotalcite.
Methotrimeprazine
Hydrotalcite can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylene blue
Hydrotalcite can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylphenidate
Hydrotalcite can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Methylprednisolone
The bioavailability of Methylprednisolone can be decreased when combined with Hydrotalcite.
Minocycline
Hydrotalcite can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Misoprostol
The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Misoprostol.
Mometasone
The bioavailability of Mometasone can be decreased when combined with Hydrotalcite.
Moricizine
Hydrotalcite can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy.
MYCOPHENOLATE
Hydrotalcite can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mycophenolic Acid
Hydrotalcite can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nalidixic Acid
Hydrotalcite can cause a decrease in the absorption of Nalidixic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Hydrotalcite.
Norfloxacin
Hydrotalcite can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
p-Hydroxyamphetamine
Hydrotalcite may decrease the excretion rate of Hydroxyamphetamine which could result in a higher serum level.
Pamidronate
The serum concentration of Pamidronate can be decreased when it is combined with Hydrotalcite.
Pamidronic Acid
The serum concentration of Pamidronate can be decreased when it is combined with Hydrotalcite.
Paramethasone
The bioavailability of Paramethasone can be decreased when combined with Hydrotalcite.
Pazopanib
The serum concentration of Pazopanib can be decreased when it is combined with Hydrotalcite.
Pefloxacin
Hydrotalcite can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Penicillamine
The serum concentration of Penicillamine can be decreased when it is combined with Hydrotalcite.
Perazine
Hydrotalcite can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Periciazine
Hydrotalcite can cause a decrease in the absorption of Propericiazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Perphenazine
Hydrotalcite can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Phentermine
Hydrotalcite may decrease the excretion rate of Phentermine which could result in a higher serum level.
PHENTERMINE RESIN
Hydrotalcite may decrease the excretion rate of Phentermine which could result in a higher serum level.
Pitavastatin
The serum concentration of Pitavastatin can be decreased when it is combined with Hydrotalcite.
Polystyrene Sulfonate
The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Tolevamer.
Polystyrene Sulfonic Acid
The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Tolevamer.
Prasterone
The bioavailability of Prasterone can be decreased when combined with Hydrotalcite.
Pravastatin
The serum concentration of Pravastatin can be decreased when it is combined with Hydrotalcite.
Prednicarbate
The bioavailability of Prednicarbate can be decreased when combined with Hydrotalcite.
Prednisolone
The bioavailability of Prednisolone can be decreased when combined with Hydrotalcite.
Prednisone
The bioavailability of Prednisone can be decreased when combined with Hydrotalcite.
Pregnenolone
The bioavailability of Pregnenolone can be decreased when combined with Hydrotalcite.
Prochlorperazine
Hydrotalcite can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promazine
Hydrotalcite can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promethazine
Hydrotalcite can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pseudoephedrine
Hydrotalcite may decrease the excretion rate of Pseudoephedrine which could result in a higher serum level.
Quinidine
Hydrotalcite may decrease the excretion rate of Quinidine which could result in a higher serum level.
Quinine
The serum concentration of Quinine can be decreased when it is combined with Hydrotalcite.
Rimexolone
The bioavailability of Rimexolone can be decreased when combined with Hydrotalcite.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Hydrotalcite.
Risedronate
The serum concentration of Risedronate can be decreased when it is combined with Hydrotalcite.
Risedronic Acid
The serum concentration of Risedronate can be decreased when it is combined with Hydrotalcite.
Rosoxacin
Hydrotalcite can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rosuvastatin
The serum concentration of Rosuvastatin can be decreased when it is combined with Hydrotalcite.
Simvastatin
The serum concentration of Simvastatin can be decreased when it is combined with Hydrotalcite.
Sodium glycerophosphate
Hydrotalcite can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Hydrotalcite can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Hydrotalcite can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate, Monobasic
Hydrotalcite can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Hydrotalcite can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sotalol
The serum concentration of Sotalol can be decreased when it is combined with Hydrotalcite.
Sparfloxacin
Hydrotalcite can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucroferric Oxyhydroxide
Hydrotalcite can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulpiride
The serum concentration of Sulpiride can be decreased when it is combined with Hydrotalcite.
Technetium Tc 99m Medronate
The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Hydrotalcite.
Temafloxacin
Hydrotalcite can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thiethylperazine
Hydrotalcite can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioproperazine
Hydrotalcite can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Thioridazine
Hydrotalcite can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tiludronate
The serum concentration of Tiludronic acid can be decreased when it is combined with Hydrotalcite.
Tiludronic Acid
The serum concentration of Tiludronic acid can be decreased when it is combined with Hydrotalcite.
Tixocortol
The bioavailability of Tixocortol can be decreased when combined with Hydrotalcite.
Triamcinolone
The bioavailability of Triamcinolone can be decreased when combined with Hydrotalcite.
Trientine
Hydrotalcite can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trifluoperazine
Hydrotalcite can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Triflupromazine
Hydrotalcite can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trimeprazine
Hydrotalcite can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin
Hydrotalcite can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Zoledronic Acid
The serum concentration of Zoledronic acid can be decreased when it is combined with Hydrotalcite.
Zoledronic Acid Anhydrous
The serum concentration of Zoledronic acid can be decreased when it is combined with Hydrotalcite.
